Start | Browse by Day | Author Index

91 Costs of cardiovascular disease associated with the use of sunitinib and sorafenib in renal-cell carcinoma

Sunday, April 26, 2009
Rex W. Force, PharmD, FCCP, BCPS , Departments of Family Medicine and Pharmacy Practice, Idaho State University and improveRX, LLC, Pocatello, ID
Kjel A. Johnson, Pharm.D , ICORE Healthcare, LLC, Orlando, FL
See more of: Scientific Poster Presentation II
See more of: Original Research
<< Previous Abstract | Next Abstract >>